YCCI News

Black girls make up a relatively small portion of the overall drug-using population. But their health consequences are more severe than most: Reproductive issues, fertility issues, sexually transmitted infections and trauma exposure are all obstacles they face at statistically higher rates compared to their peers.

Although medicine has come a long way from ancient times, misperceptions about the occurrence and cause of symptoms continue, particularly regarding the health of women.

Scientists examine the unique immune systems of children as more fall victim to COVID-19

New findings from a large study led by researchers at Yale Cancer Center shows the addition of the drugs oleclumab or monalizumab to durvalumab improved progression-free survival for patients with locally advanced non-small cell lung cancer.

Alex Kwan, PhD, Associate Professor of Psychiatry and of Neuroscience, spoke to WTNH-News 8 about his research into the use of psychedelics to treat depression in patients.

Yale School of Medicine has been awarded nearly $63.7 million over the next five years from the National Center for Advancing Translational Sciences to renew its five-year Clinical and Translational Science Award (CTSA) to accelerate research discoveries that can have a positive impact on health.

Pilot Grants Now Available Through Yale Diabetes Research Center

At Yale, a project called “Generations” is performing a 10-gene analysis to provide people with information about their risk for 10 diseases, all of them heart- or cancer-related. Anyone is eligible and the analysis is free of charge.

The Yale Psychiatry Anti-Racism Task Force has spent the last 11 months working to address issues of diversity, equity, and inclusion in the department.